Isleworth Healthcare Acquisition Corp. announced that in connection with the IPO, Vipul Patel, Marc Kozin, Robert Dahl, and Michelle McKenna were appointed to the board of directors of the Company. The board of directors has determined that the directors are independent directors within the meaning of applicable SEC and Nasdaq rules. Effective upon their appointment, (i) Ms. McKenna and Messrs. Weiss, and Kozin were appointed to the board's audit committee, with Mr. Weiss serving as chair of the audit committee; (ii) Messrs. Dahl and Patel were appointed to the board's compensation committee, with Mr. Dahl serving as chair of the compensation committee; and (iii) Messrs. Kozin, Weiss, and Patel were appointed to the board's nominating and corporate governance committee, with Mr. Kozin serving as chair of the nominating and corporate governance committee.